• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2012 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Variability in medical practice]
2012 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment of a program for tertiary prevention of osteoporosis in patients with hip fracture]
2012 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Health technology assessment report on metal on metal hip resurfacing versus total hip replacement]
2012 NIHR Health Technology Assessment programme Managing Injuries of the Neck Trial (MINT): a randomised controlled trial of treatments for whiplash injuries
2012 NIHR Health Technology Assessment programme Clinical effectiveness, cost-effectiveness and service users' perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT NoW Study)
2012 NIHR Health Technology Assessment programme Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [Inguinal hernia management: operation or observation? A randomised controlled multicenter trial]
2012 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [DETECTA-T]
2012 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Examination and treatment of older people after a fall – a health technology assessment]
2012 NIHR Health Technology Assessment programme A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [Multicentered randomized controlled trial to test the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered]
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [Implementation of a multiple intervention aimed at optimising prescription of antibiotics for respiratory tract infections, embedded within the new practice accreditation of the Dutch College of General Practitioners; a randomized controlled trial]
2012 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Routine use of CYP-test in antipsychotic drug treatment - a health technology assessment]
2012 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Hyperbaric oxygen treatment of injuries after radiotherapy for head and neck cancer - a health technology assessment]
2012 NIHR Health Technology Assessment programme Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)
2012 NIHR Health Technology Assessment programme Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antisepticimpregnated urethral catheters (the CATHETER trial)
2012 NIHR Health Technology Assessment programme Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness
2012 NIHR Health Technology Assessment programme The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS)
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [A randomised controlled trial in the palliative setting regarding off-label medication: investigating the efficiency of amitriptyline versus pregabalin from a societal perspective]
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [ACCURATE: Asthma Control Cost-Utility RAndomized Trial Evaluation Goals of asthma treatment: how high should we go?]
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of the demands and capacities model based treatment compared to the Lidcombe programme of early stuttering intervention: randomised trial]
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [Cost-effectiveness of two strategies to implement the NVOG guidelines on hypertension in pregnancy: an innovative strategy including a computerised decision support system compared to a common strategy of professional audit & feedback]
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [Development and application of clinical prediction models in the presence of multilevel data]
2012 The Netherlands Organisation for Health Research and Development (ZonMw) [Implementation of screening and treatment of high-risk fracture patients by an osteoporosis nurse-practitioner]
2012 NIHR Health Technology Assessment programme REMCARE: reminiscence groups for people with dementia and their family caregivers - effectiveness and cost-effectiveness pragmatic multicentre randomised trial
2012 NIHR Health Technology Assessment programme What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature
2012 NIHR Health Technology Assessment programme The measurement of patients' expectations for health care: a review and psychometric testing of a measure of patients' expectations
2012 NIHR Horizon Scanning Centre (NIHR HSC) Clofarabine (Evoltra) for acute myeloid leukaemia in older adults unsuitable for anthracycline-based combination chemotherapy
2012 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Falls prevention for the elderly]
2012 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Drug treatment of ADHD (Attention Deficit/Hyperactivity Disorder) in adults in Germany]
2012 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Treatment of obesity in children and adolescents in primary and secondary care settings recommendations: clinical practice guidelines]
2012 NIHR Health Technology Assessment programme Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation
2012 NIHR Health Technology Assessment programme Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation
2012 NIHR Health Technology Assessment programme A systematic review of prevention and intervention strategies for populations at high risk of engaging in violent behaviour update 2002-8
2012 NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of TA111): a systematic review and economic model
2012 NIHR Health Technology Assessment programme Mode of data elicitation, acquisition and response to surveys: a systematic review
2012 NIHR Health Technology Assessment programme Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies
2012 NIHR Health Technology Assessment programme Screening for cystic fibrosis-related diabetes: a systematic review
2012 NIHR Health Technology Assessment programme An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis
2012 NIHR Health Technology Assessment programme Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study
2012 NIHR Health Technology Assessment programme CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury - a nested randomised, placebo-controlled trial
2012 NIHR Health Technology Assessment programme Systematic review and validation of prediction rules for identifying children with serious infections in emergency departments and urgent-access primary care
2012 NIHR Health Technology Assessment programme What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review
2012 NIHR Health Technology Assessment programme A methodological study to compare survey-based and observation-based evaluations of organisational and safety cultures and then compare both approaches with markers of the quality of care
2012 NIHR Health Technology Assessment programme The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy
2012 NIHR Health Technology Assessment programme Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome)
2012 NIHR Health Technology Assessment programme Surveillance for ocular hypertension: an evidence synthesis and economic evaluation
2012 NIHR Health Technology Assessment programme Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis
2012 NIHR Health Technology Assessment programme Systematic review of head cooling in adults after traumatic brain injury and stroke
2012 NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial
2012 NIHR Health Technology Assessment programme Adapting health promotion interventions to meet the needs of ethnic minority groups: mixed-methods evidence synthesis
2012 NIHR Health Technology Assessment programme Management of frozen shoulder: a systematic review and cost-effectiveness analysis
2012 NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders
2012 NIHR Health Technology Assessment programme A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin
2012 NIHR Health Technology Assessment programme Outcomes of social care for adults: developing a preference weighted measure
2012 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical Practice Guideline on prevention and management of suicidal behaviour]
2012 The Swedish Council on Health Technology Assessment (SBU) [Occupational exposures and neck and upper extremity disorders]
2012 The Swedish Council on Health Technology Assessment (SBU) [Medicinal treatment of psychosis/schizophrenia]
2012 The Swedish Council on Health Technology Assessment (SBU) [Case finding, diagnosis and follow up of patients with affective disorders]
2012 The Swedish Council on Health Technology Assessment (SBU) [Blood test for early diagnosis of Alzheimer's disease]
2012 Medical Advisory Secretariat (MAS) Chronic Obstructive Pulmonary Disease (COPD)
2012 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Bone graft substitutes in traumatology]
2012 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Falls prevention for the elderly]
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) New oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation
2012 Belgian Health Care Knowledge Centre (KCE) Manual for cost-based pricing of hospital interventions
2012 Belgian Health Care Knowledge Centre (KCE) Hepatitis C screening and prevention
2012 Finnish Office for Health Care Technology Assessment (Finohta) [Continuous subcutaneous insulin infusion in type 1 diabetes mellitus]
2012 Finnish Office for Health Care Technology Assessment (Finohta) [Magnetic resonance imaging of primary breast cancer]
2012 Finnish Office for Health Care Technology Assessment (Finohta) [Fetal intrapartum surveillance - Does STAN improve safety? A meta-analysis]
2012 Finnish Office for Health Care Technology Assessment (Finohta) [Cystatin C in the (early) diagnosis of renal failure]
2012 Agency for Healthcare Research and Quality (AHRQ) Management of asymptomatic carotid stenosis
2012 Agency for Healthcare Research and Quality (AHRQ) The impact of pre-transplant red blood cell transfusions in renal allograph rejection
2012 Agency for Healthcare Research and Quality (AHRQ) Enabling patient-centered care through health information technology (Health IT)
2012 Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2012 Medical Advisory Secretariat (MAS) Genetic testing for predisposition to dilated cardiomyopathy
2012 Medical Services Advisory Committee (MSAC) Testing for HER-2 status in advanced or metastatic breast cancer (stage IIIA-IV) to access lapatinib
2012 Medical Services Advisory Committee (MSAC) Holmium Laser Enucleation of the Prostate (HOLEP) combined with tissue morcellation
2012 NIHR Health Technology Assessment programme Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: A systematic review and economic evaluation
2012 NIHR Health Technology Assessment programme The effectiveness of interventions to treat severe acute malnutrition in young children: a systematic review
2012 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review
2012 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model
2012 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review
2012 NIHR Health Technology Assessment programme Interventions to reduce or prevent obesity in pregnant women: a systematic review
2012 NIHR Health Technology Assessment programme Exercise interventions for the management of health related quality of life and fatigue in cancer survivors during and after treatment
2012 NIHR Health Technology Assessment programme EOS 2D/3D X-ray imaging system: a systematic review and economic evaluation
2012 NIHR Health Technology Assessment programme Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation
2012 NIHR Health Technology Assessment programme Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation
2012 NIHR Health Technology Assessment programme Rituximab for the first-line treatment of stage III–IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation
2012 NIHR Health Technology Assessment programme A systematic review of the clinical effectiveness and cost effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy
2012 NIHR Health Technology Assessment programme Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer
2012 NIHR Health Technology Assessment programme Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses
2012 NIHR Health Technology Assessment programme Abatacept for the treatment of rheumatoid arthritis after the failure of conventional disease-modifying antirheumatic drugs
2012 Medical Advisory Secretariat (MAS) Internet-based device-assisted remote monitoring of cardiovascular implantable electronic devices
2012 Agency for Healthcare Research and Quality (AHRQ) Reliability testing of the AHRQ EPC approach to grading the strength of evidence in comparative effectiveness reviews
2012 NIHR Health Technology Assessment programme Mode of data elicitation, acquisition and response to surveys: a systematic review
2012 NIHR Health Technology Assessment programme A systematic review of the clinical effectiveness and cost effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy
2012 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation
2012 NIHR Health Technology Assessment programme The measurement of patients' expectations for health care: a review and psychometric testing of a measure of patients' expectations
2012 Agency for Healthcare Research and Quality (AHRQ) Noninvasive technologies for the diagnosis of coronary artery disease in women
2012 Agency for Healthcare Research and Quality (AHRQ) Registry of patient registries (RoPR): policies and procedures